Open an account

Mesa Laboratories

MLAB · NASDAQ

$125.16+$1.86 (+1.50%)TodayMarket closed ·
Prev close $123.30

About MLAB

Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. The company is headquartered in Lakewood, Colorado and currently employs 730 full-time employees. The firm's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.

Employees
717
Headquarters
Lakewood, Colorado
Listed
Feb 29, 1984
Sector
Health Care
Industry
Life Sciences Tools & Services
Website
mesalabs.com

MLAB key statistics

Market cap
700.38M
Price-earnings ratio
145.06
Dividend yield
0.49%
Average volume
110.30K
Volume
77.23K
Open price
$123.25
High today
$128.27
Low today
$122.52
52 Week high
$144.35
52 Week low
$69.51

Mesa Laboratories (MLAB) at a glance

As of Oct 20, 2026, Mesa Laboratories (MLAB) shares are priced at $125.16, giving the company a market cap of 700.38M, a price-to-earnings ratio of 145.06 and a dividend yield of 0.49%.

Today the stock has traded between $122.52 and $128.27. The current price is 2.2% above the day's low and 2.4% below its high.

Volume so far is 77.23K shares, below the average of 110.30K shares a day.

Over the past year Mesa Laboratories has ranged from $69.51 to $144.35, and now sits 74% of the way up that range.

Mesa Laboratories met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported $0.49 per share against an estimate of $0.0306.

The average analyst price target is $127.50, 1.9% above the current price, from 2 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

0%of 2 analyst ratings say Buy
  • Buy0.0%
  • Hold100.0%
  • Sell0.0%
Price target · 3 analystsAvg $127.50
Low
$126.25
Now
$125.16
High
$131.25

MLAB earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 1585.7% on average.

  1. Q4 FY24: reported $3.70 per share against an estimate of -$0.1173
  2. Q1 FY25: reported $0.84 per share against an estimate of $0.4522
  3. Q2 FY25: reported $0.798 per share against an estimate of $1.41
  4. Q3 FY25: reported -$0.258 per share against an estimate of $1.78
  5. Q4 FY25: reported -$1.31 per share against an estimate of $1.11
  6. Q1 FY26: reported -$0.75 per share against an estimate of $0.3468
  7. Q1 FY27: reported $0.49 per share against an estimate of $0.0306
  8. Q2 FY26: reported $0.49 per share against an estimate of $0.0306

MLAB news

  • Avi Kapoor

    Dow Jumps Over 300 Points; Kohl's Posts Upbeat Earnings

  • Earnings Scheduled For November 6, 2025

  • Press releasePRNewswire

    AppLovin, Robinhood Markets and Emcor Group Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

  • 12 Health Care Stocks Moving In Tuesday's Intraday Session

  • Earnings Scheduled For August 5, 2025

  • Piero Cingari

    US Stocks Rise Despite China's Trade Fears, Palantir Defies Gravity, Gold Rallies Further: What's Driving Markets Tuesday?

Similar companies

Companies in the same industry as Mesa Laboratories

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.